Company / Financials
Tanke Biosciences Corp Financials
FY2011-FY2012 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$28.6M
FY2012 · +19.8% YoY
Net Income
-$210.2K
FY2012 · +93.3% YoY
Profit Margin
-0.7%
FY2012 · net income / revenue
ROE
-1.3%
FY2012 · return on equity
Total Assets
$28.8M
FY2012
Total Debt
$2.1M
0.13x debt/equity
Equity
$15.8M
FY2012
ROA
-0.7%
FY2012 · return on assets
Statement paths
Financial highlights
Key Data Points
- Piotroski F-Score: 2/9 criteria passed
- Altman Z-Score 2.31 (gray zone, between 1.23 and 2.9)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$28.6M+19.8% YoYNet Income HistoryProfit after all expenses and taxes-$210.2K+93.3% YoYGross Profit HistoryRevenue minus cost of goods sold$9.9M+13.4% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$18.6M+23.6% YoYOperating Income HistoryProfit from core business operations before interest and taxes$4.5M+160.6% YoYSG&A Expense HistorySelling, general, and administrative expenses$2.6M-42.7% YoYR&D Expense HistoryResearch and development spending$290.7K+18.1% YoYInterest Expense HistoryCost of borrowing and debt obligations$1.4M+6.2% YoYIncome Tax HistoryTotal income tax expense$831.6K+22.1% YoYEPS (Basic) HistoryBasic earnings per share-